WARF: P120130US01

  • Assigned to WARF as biological material.

Reprogrammed Stem Cell Line for Research: IISH3i-CB6


Igor Slukvin, Kejin Hu, James Thomson

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing a transgene-free iPSC line generated by reprogramming cord blood cells.
OVERVIEWReprogramming blood cells to induced pluripotent stem cells (iPSCs) provides a novel tool for studying blood development in vitro.
THE INVENTIONUW–Madison researchers have developed a reprogrammed iPSC line called IISH3i-CB6. Their method generates iPSCs free of transgene and vector sequences from human bone marrow and cord blood mononuclear cells using non-integrating episomal vectors.
  • Reprogrammed iPSCs for research
  • Research-grade stem cells
For More Information About the Inventors
  • Hu K., Yu J., Suknuntha K., et al. 2011. Efficient Generation of Transgene-Free Induced Pluripotent Stem Cells from Normal and Neoplastic Bone Marrow and Cord Blood Mononuclear Cells. Blood. 117, e109–e119.
Contact Information
For current licensing status, please contact Andy DeTienne at or 608-960-9857.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.